<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01702545</url>
  </required_header>
  <id_info>
    <org_study_id>PEAK-001</org_study_id>
    <nct_id>NCT01702545</nct_id>
  </id_info>
  <brief_title>Determination of Drugs and Their Metabolites in Hospitalized Patients</brief_title>
  <official_title>Determination of Drugs and Their Metabolites in Hospitalized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Nürnberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Nürnberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current state of knowledge on the concentration of drugs and their metabolites in the&#xD;
      individual human body is not satisfying concerning the question about behavior of drugs in&#xD;
      the human body, taking into account individual patient factors such as age, weight and organ&#xD;
      dysfunctions.&#xD;
&#xD;
      This projects deals with the question of drug levels in the blood of hospitalized patients.&#xD;
&#xD;
      The aim of this study is to extend the knowledge about the behavior of drugs in the human&#xD;
      body significantly, for the safety and benefit of future patients. This also includes to&#xD;
      establish a relationship between drug levels in patients and the desired and undesired&#xD;
      effects of a drug.&#xD;
&#xD;
      As a result, the future perspective is to find the optimal dose for the individual patient by&#xD;
      measuring the blood concentration of a drug.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary goal of the study is to gain an overview of the plasma concentrations of relevant&#xD;
      drugs which occur in different patient populations and to what extent they are consistent&#xD;
      with those concentrations described in the literature.&#xD;
&#xD;
      If the expectation is confirmed, that a significant heterogeneity in the plasma&#xD;
      concentrations of these patients exists, the investigators will try to find influencing&#xD;
      factors for this circumstance on the basis of routine clinical parameters (height, weight,&#xD;
      renal function, concomitant medications, etc.).&#xD;
&#xD;
      Ultimately, this project will identify substances with a high interindividual variability in&#xD;
      plasma levels, where drug monitoring might be suggested.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentrations [ng/mL] of various drugs at different timepoints</measure>
    <time_frame>up to five years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Neoplasms</condition>
  <biospec_descr>
    <textblock>
      Blood, Plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  legal capacity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe anemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Wilhelm, Prof Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Paracelsus Medical University Klinikum Nuremberg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Wilhelm, Prof. Dr.</last_name>
    <phone>00499113983050</phone>
    <email>martin.wilhelm@klinikum-nuernberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin Wilhelm, Prof Dr</last_name>
    <phone>00499113983050</phone>
    <email>martin.wilhelm@klinikum-nuernberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Internal Medicine V, Klinikum Nürnberg Nord</name>
      <address>
        <city>Nürnberg</city>
        <state>Bavaria</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Wilhelm, Prof. Dr.</last_name>
      <phone>00499113983050</phone>
      <email>martin.wilhelm@klinikum-nuernberg.de</email>
    </contact>
    <investigator>
      <last_name>Martin Wilhelm, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 1, 2012</study_first_submitted>
  <study_first_submitted_qc>October 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2012</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Nürnberg</investigator_affiliation>
    <investigator_full_name>Mr. Prof. Dr. Wilhelm</investigator_full_name>
    <investigator_title>Prof. Dr. med. Martin Wilhelm</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

